BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23108862)

  • 21. Peptide-based molecular beacons for cancer imaging and therapy.
    Liu TW; Chen J; Zheng G
    Amino Acids; 2011 Nov; 41(5):1123-34. PubMed ID: 20169374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The future of nanofabrication and molecular scale devices in nanomedicine.
    Freitas RA
    Stud Health Technol Inform; 2002; 80():45-59. PubMed ID: 12026137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical and magnetic resonance imaging as complementary modalities in drug discovery.
    Sandanaraj BS; Kneuer R; Beckmann N
    Future Med Chem; 2010 Mar; 2(3):317-37. PubMed ID: 21426169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantum dots and nanocomposites.
    Mansur HS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(2):113-29. PubMed ID: 20104596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomedicine: application of nanobiotechnology in medical practice.
    Jain KK
    Med Princ Pract; 2008; 17(2):89-101. PubMed ID: 18287791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.
    Shokeen M; Fettig NM; Rossin R
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):267-77. PubMed ID: 18475250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendrimers for theranostic applications.
    Sk UH; Kojima C
    Biomol Concepts; 2015 Jun; 6(3):205-17. PubMed ID: 26136305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
    Winter PM; Cai K; Caruthers SD; Wickline SA; Lanza GM
    Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
    Cabral H; Nishiyama N; Kataoka K
    Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of molecular imaging and nanomedicine in China.
    Shen B; Kezheng W; Xilin S; Lina W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(6):533-44. PubMed ID: 21850712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging trends of nanomedicine--an overview.
    Sandhiya S; Dkhar SA; Surendiran A
    Fundam Clin Pharmacol; 2009 Jun; 23(3):263-9. PubMed ID: 19527298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
    Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
    Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward the emergence of nanoneurosurgery: part II--nanomedicine: diagnostics and imaging at the nanoscale level.
    Leary SP; Liu CY; Apuzzo ML
    Neurosurgery; 2006 May; 58(5):805-23; discussion 805-23. PubMed ID: 16639314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanotechnology applications in medicine and dentistry.
    Gupta J
    J Investig Clin Dent; 2011 May; 2(2):81-8. PubMed ID: 25426600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions.
    Farzin L; Sheibani S; Moassesi ME; Shamsipur M
    J Biomed Mater Res A; 2019 Jan; 107(1):251-285. PubMed ID: 30358098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metal-Organic Framework-Based Nanomedicine Platforms for Drug Delivery and Molecular Imaging.
    Cai W; Chu CC; Liu G; Wáng YX
    Small; 2015 Oct; 11(37):4806-22. PubMed ID: 26193176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.
    Wicki A; Witzigmann D; Balasubramanian V; Huwyler J
    J Control Release; 2015 Feb; 200():138-57. PubMed ID: 25545217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomaterial-based activatable imaging probes: from design to biological applications.
    Li J; Cheng F; Huang H; Li L; Zhu JJ
    Chem Soc Rev; 2015 Nov; 44(21):7855-80. PubMed ID: 26214317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.